Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals Reports Its Third Consecutive Year of Profitability with Record Full Year 2008 Results
Published in Healthcare Mergers, Acquisitions and Ventures Week, March 7th, 2009
Sucampo reported full year revenue of $112.1 million for 2008 as compared to $91.9 million for 2007, an increase of $20.2 million, or 22.0%.
Product royalty revenue from sales of Amitiza® (lubiprostone) in the U.S. increased by $6.9 million, or 25.1%, to $34.4 million for 2008 from $27.5 million for 2007...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- 100 Black Men of America, Inc.
Official Statement From the 100 Black Men of America, Inc. Regarding New York Post Sean Delonas Cartoon - 1199SEIU United Healthcare Workers East
Beth Israel Deaconess Urged to Investigate Member of Board of Overseers Who Raised Millions for Madoff - 2010 Winter Games Secretariat
Accreditation opens for B.C. International Media Centre at 2010 Winter Olympic Games - 365 Main Inc.
365 Main Forms Service Company to Meet Growing Technical Needs of Customers - 3DIcon Corporation
3DIcon Files Utility Patent for Breakthrough 3D CSpace® Technology - A. O. Smith
A. O. Smith Sponsors 'Go for the Green' Sweepstakes - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
